移植診断市場規模、シェア、成長分析、技術別、製品・サービス別、用途別、移植タイプ別、エンドユーザー別、地域別 - 産業予測、2024～2031年

移植診断の世界市場規模は、2022年に43億米ドルと評価され、2023年の46億2,000万米ドルから2031年には82億4,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは7.5％で成長する見通しです。

世界の移植診断市場は、臓器移植需要の高まり、診断技術の進歩、臓器不全につながる慢性疾患の蔓延の増加などに後押しされ、力強い成長を遂げています。この市場拡大は、患者の転帰と成功率を高めるために不可欠な、正確で効率的な移植適合性検査に対する重要なニーズによってさらに支えられています。注目すべき動向は、人工知能（AI）と機械学習（ML）が移植診断に統合され、ゲノム情報や臨床情報を含む膨大なデータセットの解析が可能になったことです。これらの先進技術は、適合パターンの特定や臓器割り当ての最適化に役立つだけでなく、診断の精度と効率を大幅に向上させ、最終的には移植手術における患者の転帰とリソースの利用率を改善します。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

移植診断市場規模：技術別およびCAGR（2024～2031年）

• 市場概要
• 分子アッセイ技術
  • PCRベース分子アッセイ
  • リアルタイムPCR
  • 配列特異的プライマーPCR
  • 配列特異的オリゴヌクレオチドPCR
  • その他のPCRベース分子アッセイ
• シーケンシングベース分子アッセイ
  • サンガーシーケンス
  • 次世代シーケンシング
  • その他のシーケンシングベース分子アッセイ
• 非分子アッセイ技術

移植診断市場規模：製品・サービス別およびCAGR（2024～2031年）

• 市場概要
• 試薬・消耗品
• 機器
• ソフトウェアとサービス

移植診断市場規模：用途別およびCAGR（2024～2031年）

• 市場概要
• 診断用途
  • 移植前診断
  • 感染症検査
  • 組織適合性検査
  • 血液プロファイリング
  • 移植後診断
• 調査用途

移植診断市場規模：移植タイプ別およびCAGR（2024～2031年）

• 市場概要
• 固形臓器移植
  • 腎臓移植
  • 肝臓移植
  • 心臓移植
  • 肺移植
  • 膵臓移植
  • その他の臓器移植
• 幹細胞移植
• 軟部組織移植
• 骨髄移植

移植診断市場規模：エンドユーザー別およびCAGR（2024～2031年）

• 市場概要
• 病院と移植センター
• 調査・学術機関
• 独立リファレンスラボ

移植診断市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Abbott Laboratories（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Omixon Ltd.（Estonia）
• Hologic, Inc.（USA）
• Immucor, Inc.（USA）
• CareDx, Inc.（USA）
• Qiagen N.V.（Netherlands）
• BioGenuix, Inc.（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Fujifilm Holdings Corporation（Japan）
• Eurofins Scientific SE（Luxembourg）
• Genomatica, Inc.（USA）
• Illumina, Inc.（USA）
• Oxford Nanopore Technologies plc（UK）
• Pacific Biosciences of California, Inc.（USA）
• NanoString Technologies, Inc.（USA）
• Fluidigm Corporation（USA）
• Agilent Technologies, Inc.（USA）

結論と推奨事項

Global Transplant Diagnostics Market size was valued at USD 4.3 billion in 2022 and is poised to grow from USD 4.62 billion in 2023 to USD 8.24 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The global transplant diagnostics market is experiencing robust growth, fueled by rising organ transplantation demands, advancements in diagnostic technologies, and increasing chronic disease prevalence leading to organ failure. This market expansion is further supported by a critical need for precise and efficient transplant compatibility testing, essential for enhancing patient outcomes and success rates. A notable trend is the integration of artificial intelligence (AI) and machine learning (ML) into transplant diagnostics, enabling the analysis of vast datasets, including genomic and clinical information. These advanced technologies not only help identify compatibility patterns and optimize organ allocation but also significantly enhance the accuracy and efficiency of diagnostics, ultimately improving patient outcomes and resource utilization in transplant procedures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplant Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplant Diagnostics Market Segmental Analysis

Global Transplant Diagnostics Market is segmented by technology, product & services, application, transplant type, end user and region. Based on technology, the market is segmented into molecular assay technologies, sequencing based molecular assays and non molecular assays technologies. Based on product, the market is segmented into reagents & consumables, instruments and software & services. Based on application, the market is segmented into diagnostic application and research applications. Based on transplant type, the market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation and bone marrow transplantation. Based on end user, the market is segmented into hospitals and transplant centers, research & academic institutes and independent reference laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transplant Diagnostics Market

The Global Transplant Diagnostics market is primarily driven by the rising demand for organ transplantation procedures, largely influenced by the increasing prevalence of chronic conditions like end-stage renal disease, heart failure, and liver cirrhosis. As more patients seek effective treatments to enhance their quality of life, the recognition of organ transplantation's benefits is becoming widespread among both patients and healthcare providers. This growing awareness necessitates precise and efficient compatibility testing between donors and recipients, thereby propelling the expansion of the transplant diagnostics sector. Enhanced diagnostic methods are critical in ensuring successful transplant outcomes, further stimulating market growth.

Restraints in the Global Transplant Diagnostics Market

The Global Transplant Diagnostics market faces significant challenges due to the critical shortage of organ donors. The overwhelming demand for organ transplants surpasses the supply of suitable organs, resulting in extensive waiting lists for patients. This situation not only heightens the risk of mortality and disease advancement during these waiting periods but also hampers the performance of transplant diagnostic procedures. Consequently, the limited organ availability constrains the market potential for diagnostic products and services. Furthermore, ethical dilemmas, legal regulations, and cultural obstacles surrounding organ donation in various regions exacerbate this shortage, further restricting growth opportunities within the transplant diagnostics sector.

Market Trends of the Global Transplant Diagnostics Market

A prominent trend in the global transplant diagnostics market is the rising integration of next-generation sequencing (NGS) technology, which is transforming the landscape of organ transplantation. NGS enables comprehensive genetic profiling of both donors and recipients, significantly enhancing the matching process through detailed analysis of the human leukocyte antigen (HLA) system and other critical genetic markers. This cutting-edge approach surpasses traditional methods by accommodating a broader spectrum of HLA alleles, unveiling rare variants, and enabling the simultaneous evaluation of multiple genetic indicators. As such, NGS not only streamlines the diagnostic workflow but also holds the potential to substantially improve transplant success rates and patient outcomes through optimized donor-recipient compatibility.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Transplant Diagnostics Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Molecular Assay Technologies
  • Pcr-Based Molecular Assays
  • Real-Time Pcr
  • Sequence-Specific Primer-Pcr
  • Sequence-Specific Oligonucleotide-Pcr
  • Other Pcr-Based Molecular Assays
• Sequencing Based Molecular Assays
  • Sanger Sequencing
  • Next Generation Sequencing
  • Other Sequencing Based Molecular Assays
• Non Molecular Assays Technologies

Global Transplant Diagnostics Market Size by Product & Service & CAGR (2024-2031)

• Market Overview
• Reagents & Consumables
• Instruments
• Software & Services

Global Transplant Diagnostics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Diagnostic Application
  • Pre-Transplantation Diagnostics
  • Infectious Disease Testing
  • Histocompatibility Testing
  • Blood Profiling
  • Post -Transplantation Diagnostics
• Research Applications

Global Transplant Diagnostics Market Size by Transplant Type & CAGR (2024-2031)

• Market Overview
• Solid Organ Transplantation
  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation
  • Other Organs Transplantation
• Stem Cell Transplantation
• Soft Tissue Transplantation
• Bone Marrow Transplantation

Global Transplant Diagnostics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals and Transplant Centers
• Research & Academic Institutes
• Independent Reference Laboratories

Global Transplant Diagnostics Market Size & CAGR (2024-2031)

• North America (Technology, Product & Service, Application, Transplant Type, End User)
  • USA
  • Canada
• Europe (Technology, Product & Service, Application, Transplant Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product & Service, Application, Transplant Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product & Service, Application, Transplant Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product & Service, Application, Transplant Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omixon Ltd. (Estonia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenuix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatica, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations